Literature DB >> 33934465

An episode of mania following self-reported ingestion of psilocybin mushrooms in a woman previously not diagnosed with bipolar disorder: A case report.

Holly M Hendin1,2, Andrew D Penn3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2021        PMID： 33934465     DOI： 10.1111/bdi.13095

Source DB:  PubMed          Journal:  Bipolar Disord        ISSN： 1398-5647            Impact factor:   6.744


× No keyword cloud information.
  4 in total

Review 1.  Assessing the risk-benefit profile of classical psychedelics: a clinical review of second-wave psychedelic research.

Authors:  David Bender; David J Hellerstein
Journal:  Psychopharmacology (Berl)       Date:  2022-01-13       Impact factor: 4.530

Review 2.  Psychedelics in the treatment of unipolar and bipolar depression.

Authors:  Oliver G Bosch; Simon Halm; Erich Seifritz
Journal:  Int J Bipolar Disord       Date:  2022-07-05

3.  The effects of psilocybin on cognitive and emotional functions in healthy participants: Results from a phase 1, randomised, placebo-controlled trial involving simultaneous psilocybin administration and preparation.

Authors:  James J Rucker; Lindsey Marwood; Riikka-Liisa J Ajantaival; Catherine Bird; Hans Eriksson; John Harrison; Molly Lennard-Jones; Sunil Mistry; Francesco Saldarini; Susan Stansfield; Sara J Tai; Sam Williams; Neil Weston; Ekaterina Malievskaia; Allan H Young
Journal:  J Psychopharmacol       Date:  2022-01-04       Impact factor: 4.153

4.  The Watts Connectedness Scale: a new scale for measuring a sense of connectedness to self, others, and world.

Authors:  Rosalind Watts; Hannes Kettner; Dana Geerts; Sam Gandy; Laura Kartner; Lea Mertens; Christopher Timmermann; Matthew M Nour; Mendel Kaelen; David Nutt; Robin Carhart-Harris; Leor Roseman
Journal:  Psychopharmacology (Berl)       Date:  2022-08-08       Impact factor: 4.415
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.